Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jun 14:11:1430444.
doi: 10.3389/fmed.2024.1430444. eCollection 2024.

Long COVID management: a mini review of current recommendations and underutilized modalities

Affiliations
Review

Long COVID management: a mini review of current recommendations and underutilized modalities

Tiffany K Dietz et al. Front Med (Lausanne). .

Abstract

Long COVID is a condition that develops in a subset of patients after COVID-19 infection comprising of symptoms of varying severity encompassing multiple organ systems. Currently, long COVID is without consensus on a formal definition, identifiable biomarkers, and validated treatment. Long COVID is expected to be a long-term chronic condition for a subset of patients and is associated with suffering and incapacity. There is an urgent need for clear management guidelines for the primary care provider, who is essential in bridging the gap with more specialized care to improve quality of life and functionality in their patients living with long COVID. The purpose of this mini review is to provide primary care providers with the latest highlights from existing literature regarding the most common long COVID symptoms and current management recommendations. This review also highlights the underutilized interventions of stellate ganglion blocks and low-dose naltrexone, both with well-established safety profiles demonstrated to improve quality of life and functionality for patients suffering with some symptoms of long COVID, and encourages prompt referral to interventional pain management.

Keywords: chronic COVID-19; long COVID; low-dose naltrexone; management; post COVID; post-acute sequelae of SARS-CoV-2; stellate ganglion block.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. . The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Mil Med Res. (2020) 7:11. doi: 10.1186/s40779-020-00240-0, PMID: - DOI - PMC - PubMed
    1. Yan Z, Yang M, Lai CL. Long COVID-19 syndrome: a comprehensive review of its effect on various organ systems and recommendation on rehabilitation plans. Biomedicines. (2021) 9:966. doi: 10.3390/biomedicines9080966, PMID: - DOI - PMC - PubMed
    1. Li R, Qin C. Expression pattern and function of SARS-CoV-2 receptor ACE2. Biosaf Health. (2021) 3:312–8. doi: 10.1016/j.bsheal.2021.08.003, PMID: - DOI - PMC - PubMed
    1. Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. (2023) 21:133–46. doi: 10.1038/s41579-022-00846-2 - DOI - PMC - PubMed
    1. Woodrow M, Carey C, Ziauddeen N, Thomas R, Akrami A, Lutje V, et al. . Systematic review of the prevalence of long COVID. Open forum. Infect Dis. (2023) 10:ofad233. doi: 10.1093/ofid/ofad233, PMID: - DOI - PMC - PubMed